Estrogen Receptor β Agonists Differentially Affect the Growth of Human Melanoma Cell Lines.
Cutaneous melanoma is an aggressive malignancy; its incidence is increasing worldwide and its prognosis remains poor. Clinical observations indicate that estrogen receptor β (ERβ) is expressed in melanoma tissues and its expression decreases with tumor progression, suggesting its tumor suppressive f...
Main Authors: | Monica Marzagalli, Lavinia Casati, Roberta M Moretti, Marina Montagnani Marelli, Patrizia Limonta |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4520550?pdf=render |
Similar Items
-
Estrogen Receptor β in Melanoma: From Molecular Insights to Potential Clinical Utility
by: Monica Marzagalli, et al.
Published: (2016-10-01) -
Gonadotropin-Releasing Hormone Receptors in Prostate Cancer: Molecular Aspects and Biological Functions
by: Fabrizio Fontana, et al.
Published: (2020-12-01) -
Gonadotropin-releasing hormone agonists sensitize, and resensitize, prostate cancer cells to docetaxel in a p53-dependent manner.
by: Roberta M Moretti, et al.
Published: (2014-01-01) -
Role of Endoplasmic Reticulum Stress in the Anticancer Activity of Natural Compounds
by: Patrizia Limonta, et al.
Published: (2019-02-01) -
Estrogen receptor β agonist inhibits proliferation of endometrial stromal cells in an estrogen-receptor independent manner
by: Xia Qiong, et al.
Published: (2014-01-01)